Binocs with offices in Belgium, The Netherlands, Switzerland, Ireland and United States, is a global provider of AI/ML based orchestrated scheduling and forecast planning needs and has been specifically designed to address the challenges in Cell & Gene therapy industry. Binocs can assist therapy developers in efficiently manage internal and external resources to create a great customer (HCPs) and patient experience by providing real-time updates and information on the development of individual therapeutics. Binocs is already supporting commercial CAR-T and many other late & early-stage clinical studies.